BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38188883)

  • 1. Pulmonary involvement in primary Sjögren's syndrome: contribution of the different means in the systematic investigation.
    Jridi M; Cherif Y; Derbal S; Dahmen FB; Abdallah M
    Pan Afr Med J; 2023; 46():42. PubMed ID: 38188883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.
    Dong X; Zhou J; Guo X; Li Y; Xu Y; Fu Q; Lu Y; Zheng Y
    Clin Rheumatol; 2018 Nov; 37(11):2981-2988. PubMed ID: 30242640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome.
    Kampolis CF; Fragkioudaki S; Mavragani CP; Zormpala A; Samakovli A; Moutsopoulos HM
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):94-101. PubMed ID: 29846161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI.
    Heus A; Arends S; Van Nimwegen JF; Stel AJ; Nossent GD; Bootsma H
    Scand J Rheumatol; 2020 Jan; 49(1):38-46. PubMed ID: 31556344
    [No Abstract]   [Full Text] [Related]  

  • 5. Interstitial lung disease in Primary Sjögren's syndrome.
    Lin W; Xin Z; Zhang J; Liu N; Ren X; Liu M; Su Y; Liu Y; Yang L; Guo S; Yang Y; Li Y; Cao J; Ning X; Li J; Xue H; Niu N; Chen Y; Li F; Sun L; Zhang X; Zhang F; Zhang W
    BMC Pulm Med; 2022 Feb; 22(1):73. PubMed ID: 35220958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary manifestations of Sjögren's syndrome.
    Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
    Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial lung disease in primary Sjögren's syndrome.
    Roca F; Dominique S; Schmidt J; Smail A; Duhaut P; Lévesque H; Marie I
    Autoimmun Rev; 2017 Jan; 16(1):48-54. PubMed ID: 27682894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.
    Amlani B; Elsayed G; Barvalia U; Kanne JP; Meyer KC; Sandbo N; Li Z; McCoy SS
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):136-147. PubMed ID: 33093777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
    Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
    Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
    La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
    Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
    Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
    Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease is common in never-smoking patients with primary Sjögren syndrome.
    Nilsson AM; Diaz S; Theander E; Hesselstrand R; Piitulainen E; Ekberg O; Wollmer P; Mandl T
    J Rheumatol; 2015 Mar; 42(3):464-71. PubMed ID: 25593235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement.
    Manfredi A; Sebastiani M; Cerri S; Cassone G; Bellini P; Casa GD; Luppi F; Ferri C
    Clin Rheumatol; 2017 Jun; 36(6):1261-1268. PubMed ID: 28324200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.
    He SH; He YJ; Guo KJ; Liang X; Li SS; Li TF
    Clin Rheumatol; 2022 Apr; 41(4):1153-1161. PubMed ID: 34757493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosing interstitial lung disease in primary Sjogren syndrome.
    Manfredi A; Vacchi C; DellaCasa G; Cerri S; Cassone G; Di Cecco G; Luppi F; Salvarani C; Sebastiani M
    Joint Bone Spine; 2021 Dec; 88(6):105237. PubMed ID: 34118430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung involvement of primary Sjögren's syndrome].
    Yan SM; Zhao Y; Zeng XF; Zhang FC; Dong Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jul; 31(7):513-6. PubMed ID: 19035231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
    Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
    Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of primary Sjögren's syndrome related lymphocytic interstitial pneumonia.
    Dong X; Gao YL; Lu Y; Zheng Y
    Clin Rheumatol; 2021 Feb; 40(2):601-612. PubMed ID: 32613392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?
    Yazisiz V; Arslan G; Ozbudak IH; Turker S; Erbasan F; Avci AB; Ozbudak O; Terzioglu E
    Rheumatol Int; 2010 Aug; 30(10):1317-24. PubMed ID: 19844720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjögren's syndrome-associated interstitial lung disease: A multicenter study.
    Reina D; Roig Vilaseca D; Torrente-Segarra V; Cerdà D; Castellví I; Díaz Torné C; Moreno M; Narváez J; Ortiz V; Blavia R; Martín-Baranera M; Corominas H
    Reumatol Clin; 2016; 12(4):201-5. PubMed ID: 26573882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.